journal cover

Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis

Acta Oncologica

Feb 15, 2020

Anouk E J LatensteinDutch Pancreatic Cancer Group

Download from

Publisher
PubMed

Abstract

Background: Positive results of randomized trials led to the introduction of FOLFIRINOX in 2012 and gemcitabine with nab-paclitaxel in 2015 for patients with metastatic pancreatic ductal adenocarcinoma. It is unknown to which extent these new chemotherapeutic regimens have been implemen...read more

Mentioned in this Paper

Fluorouracil/Irinotecan/Leucovorin Calcium/Oxaliplatin
Chemotherapy Regimen
130-nm albumin-bound paclitaxel
Cisplatin/Gemcitabine
Clinical Trials, Randomized
Administration of Antineoplastic Agent
Diagnosis
Regression Analysis
Research Activities
Pancreatic Ductal Adenocarcinoma
Paper Details
References
  • References25
  • Citations
123
  • References25
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Feeds With Similar Papers

Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma holds a significant mortality risk, largely due to its late diagnosis and ineffective chemotherapeutic response. This gastrointestinal malignancy offers a poor prognosis and the only potential cure is through surgical resection. Here are the latest discoveries pertaining to this disease.

© 2020 Meta ULC. All rights reserved

Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis

Acta Oncologica

Feb 15, 2020

Anouk E J LatensteinDutch Pancreatic Cancer Group

PMID: 32056483

DOI: 10.1080/0284186x.2020.1725241

Abstract

Background: Positive results of randomized trials led to the introduction of FOLFIRINOX in 2012 and gemcitabine with nab-paclitaxel in 2015 for patients with metastatic pancreatic ductal adenocarcinoma. It is unknown to which extent these new chemotherapeutic regimens have been implemen...read more

Mentioned in this Paper

Fluorouracil/Irinotecan/Leucovorin Calcium/Oxaliplatin
Chemotherapy Regimen
130-nm albumin-bound paclitaxel
Cisplatin/Gemcitabine
Clinical Trials, Randomized
Administration of Antineoplastic Agent
Diagnosis
Regression Analysis
Research Activities
Pancreatic Ductal Adenocarcinoma

Feeds With Similar Papers

Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma holds a significant mortality risk, largely due to its late diagnosis and ineffective chemotherapeutic response. This gastrointestinal malignancy offers a poor prognosis and the only potential cure is through surgical resection. Here are the latest discoveries pertaining to this disease.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine

FOLFIRINOX, nab-paclitaxel + gemcitabine

Nihon rinsho. Japanese journal of clinical medicineApril 11, 2015
Satoshi Shimizu
Paper Details
References
  • References25
  • Citations
123
  • References25
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Download from

Publisher
PubMed
/papers/implementation-of-contemporary-chemotherapy-for/32056483